Skip to Content

Biotwin Oncology AI — Precision Cancer Care Powered by Digital Twins & AI

.

What Is It?

Biotwin Oncology AI is Rodovita’s flagship platform for personalized oncology. It creates a digital twin of each cancer patient, simulates treatment response, predicts risks, and guides physicians with AI-powered insights.
One platform. One patient. A thousand variables aligned for the right decision.

  How It Works?

  • Create the patient’s Biotwin
     – Genomics, biomarkers, imaging, labs, voice & sensor data ​
  • Model the tumor in 3D
     – CT/MRI segmentation, microinvasion mapping, vascular modeling ​

  • Simulate therapy response (AI Engine)
     – Predict immuno-, targeted, chemo response using AI + datasets 

  • Test therapy on patient-derived organoids
     – Ex vivo validation with Organ-on-a-Chip ​

  • Record results as NFT
     – Immutable data traceability, regulatory alignment​

  • Optional DAO review
     – Clinician community feedback, scenario approval​
    ​

 Platform Modules

  • Biotwin Engine — real-time patient modeling

  • Tumor Twin Simulator — 3D cancer reconstruction

  • Therapy Predictor — AI-based response forecasting

  • Organoid LabLink — live feedback from ex vivo testing

  • NFT/DAO Core — data certification, governance, IP trace


Who It's For 

  • Oncologists: AI clinical decision support

  • Clinics: Precision therapy infrastructure

  • Labs: Organoid testing & integration

  • Researchers: Access to anonymized case models

  • Patients: Transparency, understanding, and options

    •  

    Extended Features

 
  • Mobile-based patient monitoring

  • Voice-based emotional state analysis

  • “AI Tip of the Day” for patients

  • NFT case gallery with anonymized data

  • DAO voting on therapeutic pathways

Want to pilot Biotwin Oncology AI in your clinic?

We’re building collaborative pilot programs with real-world clinical impact.

Get in touch